Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 16, 2025Cell Death and DiseaseOpen Access

Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL

View Full Paper
Ask AI
Bookmark
Share

Authors

AVAimilia VareliHNHaripriya Vaidehi NarayananHCH. Brent Clark

Discussion

Loading...

Member takes

Overview

Observational analysis revealed therapeutic vulnerabilities in DLBCL, indicating NF-κB and BCL2 inhibition may improve treatment outcomes.

Key Points

  • Inhibiting both NF-κB and BCL2 can restore sensitivity to BH3-mimetics in DLBCL.
  • High basal NF-κB activity mediates resistance, requiring targeted inhibition for effectiveness.
  • Utilizing systems biology enabled identification of specific resistance mechanisms within cellular sub-populations.
  • Approaching therapy with combined molecular fingerprinting and computational modeling showcases promise for DLBCL treatment.

Cite This Study

Vareli et al. (2025) studied this question.

synapsesocial.com/papers/68af2d7ccf1dd9ea359e5918https://doi.org/10.1038/s41419-025-07942-0
View Full Paper
Ask AI
Bookmark
Share